Patient predictors for outcome of gonadotrophin ovulation induction in women with normogonadotrophic anovulatory infertility: A meta-analysis

Human Reproduction Update

Volumn 9, Issue 5, 2003, Pages 429-449

  Mulders, Annemarie G M G J ^a   Laven, Joop S E ^a   Eijkemans, Marinus J C ^a   Hughes, Edward G ^b   Fauser, Bart C J M ^a  

^a ERASMUS MEDICAL CENTER   (Netherlands)

^b MCMASTER UNIVERSITY   (Canada)

Author keywords

Anovulatory infertility; Meta analysis; Obesity; Outcome predictors; Ovulation induction

Indexed keywords

ANDROGEN; BROMOCRIPTINE; CHORIONIC GONADOTROPIN; CLOMIFENE CITRATE; FOLLITROPIN; FOLLITROPIN DERIVATIVE; GONADOTROPIN; HUMAN MENOPAUSAL GONADOTROPIN; LUTEINIZING HORMONE; RECOMBINANT FOLLITROPIN; TAMOXIFEN; TESTOSTERONE;

ANDROGEN BLOOD LEVEL; BODY MASS; CONFIDENCE INTERVAL; CONTROLLED STUDY; DOSE RESPONSE; FEMALE; FEMALE GENITAL TRACT PARAMETERS; FEMALE INFERTILITY; HUMAN; HYPERINSULINEMIA; INSULIN RESISTANCE; INSULIN SENSITIVITY; LUTEINIZING HORMONE BLOOD LEVEL; MAXIMUM TOLERATED DOSE; META ANALYSIS; OBESITY; OVARY HYPERSTIMULATION; OVULATION INDUCTION; PREDICTION; PREGNANCY RATE; PRIORITY JOURNAL; REVIEW; SCREENING TEST; SPONTANEOUS ABORTION; STATISTICAL SIGNIFICANCE; TESTOSTERONE BLOOD LEVEL; TREATMENT OUTCOME; ULTRASOUND;

ABORTION, SPONTANEOUS; ANOVULATION; FEMALE; FOLLICLE STIMULATING HORMONE; GONADOTROPINS; HUMANS; INFERTILITY, FEMALE; INSULIN RESISTANCE; OBESITY; OVULATION INDUCTION; PREGNANCY; REFERENCE VALUES; TREATMENT OUTCOME;

EID: 0242391979     PISSN: 13554786     EISSN: None     Source Type: Journal    
DOI: 10.1093/humupd/dmg035     Document Type: Review

References (72)

1. Abdel, G.A., Mowafi, R.S., Alnaser, H.M., Alrashid, A.H., Alonezi, O.M. and Shaw, R.W. (1990) Ovarian electrocautery versus human menopausal gonadotrophins and pure follicle stimulating hormone therapy in the treatment of patients with polycystic ovarian disease. Clin. Endocrinol. (Oxf.), 33, 585-592.
2. Adams, J., Franks, S., Polson, D.W., Mason, H.D., Abdulwahid, N., Tucker, M., Morris, D.V., Price, J. and Jacobs, H.S. (1985) Multifollicular ovaries: clinical and endocrine features and response to pulsatile gonadotropin releasing hormone. Lancet, 2, 1375-1379.
3. Adams, J., Polson, D.W. and Franks, S. (1986) Prevalence of polycystic ovaries in women with anovulation and idiopathic hirsutism. Br. Med. J. (Clin. Res. Ed.), 293, 355-359.
4. Balasch, J., Tur, R., Alvarez, P., Bajo, J.M., Bosch, E., Bruna, I., Caballero, P., Calaf, J., Cano, I., Carrillo, E. et al. (1996) The safety and effectiveness of stepwise and low-dose administration of follicle stimulating hormone in WHO group II anovulatory infertile women: evidence from a large multicenter study in Spain. J. Assist. Reprod. Genet., 13, 551-556.
5. Balen, A.H., Tan, S.L., MacDougall, J. and Jacobs, H.S. (1993) Miscarriage rates following in-vitro fertilization are increased in women with polycystic ovaries and reduced by pituitary desensitization with buserelin. Hum. Reprod., 8, 959-964.
6. CoelinghBennink, H., Fauser, B.C. and Out, H.J. (1998) Recombinant follicle-stimulating hormone (FSH; Puregon) is more efficient than urinary FSH (Metrodin) in women with clomiphene citrate-resistant, normogonadotropic, chronic anovulation: a prospective, multicenter, assessor-blind, randomized, clinical trial. European Puregon Collaborative Anovulation Study Group. Fertil. Steril., 69, 19-25.
7. Dale, O., Tanbo, T., Lunde, O. and Abyholm, T. (1993) Ovulation induction with low-dose follicle-stimulating hormone in women with the polycystic ovary syndrome. Acta Obstet. Gynecol. Scand., 72, 43-46.
8. Dale, P.O., Tanbo, T., Haug, E. and Abyholm, T. (1998) The impact of insulin resistance on the outcome of ovulation induction with low-dose follicle stimulating hormone in women with polycystic ovary syndrome. Hum. Reprod., 13, 567-570.
9. DerSimonian, R. and Laird, N. (1986) Meta-analysis in clinical trials. Control. Clin. Trials, 7, 177-188.
10. Dewailly, D. (1997) Definition and significance of polycystic ovaries. Baillières Clin. Obstet. Gynecol., 11, 349-368.
11. Dewailly, D., Robert, Y., Helin, I., Ardaens, Y., Thomas-Desrousseaux, P., Lemaitre, L. and Fossati, P. (1994) Ovarian stromal hypertrophy in hyperandrogenic women. Clin. Endocrinol. (Oxf.), 41, 557-562.
12. Dunaif, A. (1999) Insulin action in the polycystic ovary syndrome. Endocrinol. Metab. Clin. North. Am., 28, 341-359.
13. Dunaif, A, Givens, J.R. and Haseltine, F.P. (1992) The polycystic ovary syndrome. In Dunaif, A, Givens, J.R. and Haseltine, F.P. (eds), The Polycystic Ovary Syndrome. Blackwell, Boston, pp. 377-384.
14. ESHRE Capri Workshop Group (1995) Anovulatory infertility. Hum. Reprod., 10, 1549-1553.
15. Farhi, J., Homburg, R., Lerner, A. and Ben Rafael, Z. (1993) The choice of treatment for anovulation associated with polycystic ovary syndrome following failure to conceive with clomiphene. Hum. Reprod, 8, 1367-1371.
16. Fauser, B.C. and van Heusden, A.M. (1997) Manipulation of human ovarian function: physiological concepts and clinical consequences. Endocr. Rev., 18, 71-106.
17. Fluker, M.R., Urman, B., Mackinnon, M., Barrow, S.R., Pride, S.M. and Yuen, B.H. (1994) Exogenous gonadotropin therapy in World Health Organization groups I and II ovulatory disorders. Obstet. Gynecol., 83, 189-196.
18. Franks, S. and Gilling-Smith, C. (1994) Advances in induction of ovulation. Curr. Opin. Obstet. Gynecol., 6, 136-140.
19. Fulghesu, A.M., Villa, P., Pavone, V., Guido, M., Apa, R., Caruso, A., Lanzone, A., Rossodivita, A. and Mancuso, S. (1997) The impact of insulin secretion on the ovarian response to exogenous gonadotropins in polycystic ovary syndrome. J. Clin. Endocrinol. Metab., 82, 644-648.
20. Ginsburg, J. and Hardiman, P. (1991) Ovulation induction with human menopausal gonadotropins - a changing scene. Gynecol. Endocrinol., 5, 57-78.
21. Giudice, L.C. (1999) Growth factor action on ovarian function in polycystic ovary syndrome. Endocrinol. Metab. Clin. North. Am., 28, 325-39.
22. Glueck, C.J., Phillips, H., Cameron, D., Sieve-Smith, L. and Wang, P. (2001) Continuing metformin throughout pregnancy in women with polycystic ovary syndrome appears to safety reduce first-trimester spontaneous abortion: a pilot study. Fertil. Steril., 75, 46-52.
23. Hamilton-Fairley, D., Kiddy, D., Watson, H., Sagle, M. and Franks, S. (1991) Low-dose gonadotrophin therapy for induction of ovulation in 100 women with polycystic ovary syndrome. Hum. Reprod., 6, 1095-1099.
24. Hamilton-Fairley, D., Kiddy, D., Watson, H., Paterson, C. and Franks, S. (1992) Association of moderate obesity with a poor pregnancy outcome in women with polycystic ovary syndrome treated with low dose gonadotrophin. Br. J. Obstet. Gynecol., 99, 128-131.
25. Hardy, R.J. and Thompson, S.G. (1998) Detecting and describing heterogeneity in meta-analysis. Stat. Med., 17, 841-856.
26. Holte, J., Bergh, T., Berne, C., Wide, L. and Lithell, H. (1995) Restored insulin sensitivity but persistently increased early insulin secretion after weight loss in obese women with polycystic ovary syndrome. J. Clin. Endocrinol. Metab., 80, 2586-2593.
27. Homburg, R., Orvieto, R., Bar-Hava, I. and Ben Rafael, Z. (1996) Serum levels of insulin-like growth factor-1, IGF binding protein-1 and insulin and the response to human menopausal gonadotrophins in women with polycystic ovary syndrome. Hum. Reprod., 11, 716-719.
28. Howles, C.M., Macnamee, M.C., Edwards, R.G., Goswamy, R. and Steptoe, P.C. (1986) Effect of high tonic levels of luteinising hormone on outcome of in-vitro fertilisation. Lancet, 2, 521-522.
29. Imani, B., Eijkemans, M.J., te Velde, E.R., Habbema, J.D. and Fauser, B.C. (1998) Predictors of patients remaining anovulatory during clomiphene citrate induction of ovulation in normogonadotropic oligoamenorrheic infertility. J. Clin. Endocrinol. Metab., 83, 2361-2365.
30. Imani, B., Eijkemans, M.J., te Velde, E.R., Habbema, J.D. and Fauser, B.C. (1999) Predictors of chances to conceive in ovulatory patients during clomiphene citrate induction of ovulation in normogonadotropic oligoamenorrheic infertility. J. Clin. Endocrinol. Metab., 84, 1617-1622.
31. Imani, B., Eijkemans, M.J., de Jong, F.H., Payne, N.N., Bouchard, P., Giudice, L.C. and Fauser, B.C. (2000) Free androgen index and leptin are the most prominent endocrine predictors of ovarian response during clomiphene citrate induction of ovulation in normogonadotropic oligoamenorrheic infertility. J. Clin. Endocrinol. Metab., 85, 676-682.
32. Imani, B., Eijkemans, M.J., te Velde, E.R., Habbema, J.D. and Fauser, B.C. (2002a) A nomogram to predict the probability of live birth after clomiphene citrate induction of ovulation in normogonadotropic oligoamenorrheic infertility. Fertil. Steril., 77, 91-97.
33. Imani, B., Eijkemans, M.J., Faessen, G.H., Bouchard, P., Giudice, L.C. and Fauser, B.C. (2002b) Prediction of the individual follicle-stimulating hormone threshold for gonadotropin induction of ovulation in normogonadotropic anovulatory infertility: an approach to increase safety and efficiency. Fertil. Steril., 77, 83-90.
34. Insler, V. (1988) Gonadotropin therapy: new trends and insights. Int. J. Fertil., 33, 85-97.
35. Jonard, S., Robert, Y., Cortet-Rudelli, C., Pigny, P., Decanter, C. and Dewailly, D. (2003) Ultrasound examination of polycystic ovaries: is it worth counting the follicles? Hum. Reprod., 18, 598-603.
36. Kelly, A.C. and Jewelewicz, R. (1990) Alternate regimens for ovulation induction in polycystic ovarian disease. Fertil. Steril., 54, 195-202.
37. Kiddy, D.S., Hamilton-Fairley, D., Bush, A., Short, F., Anyaoku, V., Reed, M.J. and Franks, S. (1992) Improvement in endocrine and ovarian function during dietary treatment of obese women with polycystic ovary syndrome. Clin. Endocrinol. (Oxf.), 36, 105-111.
38. Lass, A., Vassiliev, A., Decosterd, G., Warne, D. and Loumaye, E. (2002) Relationship of baseline ovarian volume to ovarian response in World Health Organization II anovulatory patients who underwent ovulation induction with gonadotropins. Fertil. Steril., 78, 265-269.
39. Laven, J.S., Imani, B., Eijkemans, M.J. and Fauser, B.C. (2002) New approach to polycystic ovary syndrome and other forms of anovulatory infertility. Obstet. Gynecol. Surv., 57, 755-767.
40. Lunenfeld, B. and Insler, V. (1974) Classification of amenorrhoeic states and their treatment by ovulation induction. Clin. Endocrinol. (Oxf.), 3, 223-237.
41. Lunenfeld, B., Mashiach, S. and Blankstein, J. (1985) Induction of ovulation with gonadotrophins. In Shearman, R.P. (ed.), Clinical Reproductive Endocrinology, Churchill Livingstone, Edinburgh, UK, pp. 523-533.
42. Mannaerts, B., Shoham, Z., Schoot, D., Bouchard, P., Harlin, J., Fauser, B., Jacobs, H., Rombout, F. and Coelingh Bennink, H. (1993) Single-dose pharmacokinetics and pharmacodynamics of recombinant human follicle-stimulating hormone (Org 32489*) in gonadotropin-deficient volunteers. Fertil. Steril., 59, 108-114.
43. McClure, N., McQuinn, B., McDonald, J., Kovacs, G.T., Healy, D.L. and Burger, H.G. (1992) Body weight, body mass index, and age: predictors of menotropin dose and cycle outcome in polycystic ovarian syndrome? Fertil. Steril., 58, 622-624.
44. McClure, N., McDonald, J., Kovacs, G.T., Healy, D.L., McCloud, P.I., McQuinn, B. and Burger, H. G. (1993) Age and follicular phase estradiol are better predictors of pregnancy outcome than luteinizing hormone in menotropin ovulation induction for anovulatory polycystic ovarian syndrome. Fertil. Steril., 59, 729-733.
45. Mulders, A., Eijkemans, M., Imani, B. and Fauser, B. (2003) Prediction of chances for success or complications in gonadotropin ovulation induction in normogonadotropic anovulatory infertility. Reprod. Biomed. Online, 7, 170-178.
46. Navot, D., Bergh, P.A. and Laufer, N. (1992) Ovarian hyperstimulation syndrome in novel reproductive technologies: prevention and treatment. Fertil. Steril., 58, 249-261.
47. Norman, R.J., Davies, M.J., Lord, J. and Moran, L.J. (2002) The role of lifestyle modification in polycystic ovary syndrome. Trends Endocrinol. Metab., 13, 251-257.
48. Obhrai, M., Lynch, S.S., Holder, G., Jackson, R., Tang, L. and Butt, W.R. (1990) Hormonal studies on women with polycystic ovaries diagnosed by ultrasound. Clin. Endocrinol. (Oxf.), 32, 467-474.
49. Pache, T.D., Wladimiroff, J.W., de Jong, F.H., Hop, W.C. and Fauser, B.C. (1990) Growth patterns of nondominant ovarian follicles during the normal menstrual cycle. Fertil. Steril., 54, 638-642.
50. Pache, T.D., Wladimiroff, J.W., Hop, W.C. and Fauser, B.C. (1992) How to discriminate between normal and polycystic ovaries: transvaginal US study. Radiology, 183, 421-423.
51. Polson, D.W., Mason, H.D., Saldahna, M.B. and Franks, S. (1987) Ovulation of a single dominant follicle during treatment with low-dose pulsatile follicle stimulating hormone in women with polycystic ovary syndrome. Clin. Endocrinol. (Oxf.), 26, 205-212.
52. Poretsky, L., Cataldo, N.A., Rosenwaks, Z. and Giudice, L.C. (1999) The insulin-related ovarian regulatory system in health and disease. Endocr. Rev., 20, 535-582.
53. Puzigaca, Z., Prelevic, G.M., Stretenovic, Z. and Balint-Peric, L. (1991) Ovarian enlargement as a possible marker of androgen activity in polycystic ovary syndrome. Gynecol. Endocrinol., 5, 167-174.
54. Remorgida, V., Venturini, P.L., Anserini, P., Salerno, E. and de Cecco, L. (1991) Use of combined exogenous gonadotropins and pulsatile gonadotropin- releasing hormone in patients with polycystic ovarian disease. Fertil. Steril., 55, 61-65.
55. Rowe, P.J., Comhaire, F.H., Hargreave, T.B. and Mellows H. (2000) Female partner. In Rowe, P.J., Comhaire, F.H., Hargreave, T.B. and Mellows, H. (eds), WHO Manual for the Standardized Investigation and Diagnosis of the Infertile Couple. Press Syndicate of the University of Cambridge, Cambridge, pp. 40-67.
56. Sagle, M.A., Hamilton-Fairley, D., Kiddy, D.S. and Franks, S. (1991) A comparative, randomized study of low-dose human menopausal gonadotropin and follicle-stimulating hormone in women with polycystic ovarian syndrome. Fertil. Steril., 55, 56-60.
57. Schenker, J.G., Yarkoni, S. and Granat, M. (1981) Multiple pregnancies following induction of ovulation. Ferti. Steril., 35, 105-123.
58. Schipper, I., Rommerts, F.F., Ten Hacken, P.M. and Fauser, B.C. (1997) Low levels of follicle-stimulating hormone receptor-activation inhibitors in serum and follicular fluid from normal controls and anovulatory patients with or without polycystic ovary syndrome. J. Clin. Endocrinol. Metab., 82, 1325-1331.
59. Schwartz, M. and Jewelewicz, R. (1981) The use of gonadotropins for induction of ovulation. Fertil. Steril., 35, 3-12.
60. Shoham, Z., Patel, A. and Jacobs, H.S. (1991) Polycystic ovarian syndrome: safety and effectiveness of stepwise and low-dose administration of purified follicle-stimulating hormone. Fertil. Steril., 55, 1051-1056.
61. Stephenson, P.A. (1991) The risks associated with ovulation induction. Iatrogenics, 1, 7-16.
62. Strowitzki, T., Seehaus, D., Korell, M. and Hepp, H. (1994) Low-dose follicle stimulating hormone for ovulation induction in polycystic ovary syndrome. J. Reprod. Med., 39, 499-503.
63. Strowitzki, T., Seehaus, D., Korell, M. and Hepp, H. (1998) Low-dose FSH stimulation in polycystic ovary syndrome: comparison of 3 FSH-preparations. Exp. Clin. Endocrinol. Diabetes, 106, 435-439.
64. VanderMeerM., Hompes, P.G., De Boer, J.A., Schats, R. and Schoemaker, J. (1998) Cohort size rather than follicle-stimulating hormone threshold level determines ovarian sensitivity in polycystic ovary syndrome. J. Clin. Endocrinol. Metab., 83, 423-426.
65. van Dessel, H.J., Lee, P.D., Faessen, G., Fauser, B.C. and Giudice, L.C. (1999) Elevated serum levels of free insulin-like growth factor I in polycystic ovary syndrome. J. Clin. Endocrinol. Metab., 84, 3030-3035.
66. van Santbrink, E.J. and Fauser, B.C. (1997) Urinary follicle-stimulating hormone for normogonadotropic clomiphene-resistant anovulatory infertility: prospective, randomized comparison between low dose step-up and step-down dose regimens. J. Clin. Endocrinol. Metab., 82, 3597-3602.
67. van Santbrink, E.J., Hop, W.C. and Fauser, B.C. (1997) Classification of normogonadotropic infertility: polycystic ovaries diagnosed by ultrasound versus endocrine characteristics of polycystic ovary syndrome. Fertil. Steril., 67, 452-458.
68. Vicino, M., Loverro, G., Bettocchi, S., Simonetti, S., Mei, L. and Selvaggi, L. (2000) Predictive value of serum androstenedione basal levels on the choice of gonadotropin or laparoscopic ovarian electrocautery as ovulation induction in clomiphene citrate-resistant patients with polycystic ovary syndrome. Gynecol. Endocrinol., 14, 42-49.
69. Watson, H., Kiddy, D.S., Hamilton-Fairley, D., Scanlon, M.J., Barnard, C., Collins, W.P., Bonney, R.C. and Franks, S. (1993) Hypersecretion of luteinizing hormone and ovarian steroids in women with recurrent early miscarriage. Hum. Reprod., 8, 829-833.
70. White, D.M., Polson, D.W., Kiddy, D., Sagle, P., Watson, H., Gilling-Smith, C., Hamilton-Fairley, D. and Franks, S. (1996) Induction of ovulation with low-dose gonadotropins in polycystic ovary syndrome: an analysis of 109 pregnancies in 225 women. J. Clin. Endocrinol. Metab., 81, 3821-3824.
71. Yarali, H., Bukulmez, O. and Gurgan, T. (1999) Urinary follicle-stimulating hormone (FSH) versus recombinant FSH in clomiphene citrate-resistant, normogonadotropic, chronic anovulation: a prospective randomized study. Fertil. Steril., 72, 276-281.
72. Zullo, F., Di Carlo, C., Pellicano, M., Catizone, C., Mastrantonio, P. and Nappi, C. (1996) Superovulation with urinary human follicle-stimulating hormone: correlations with body mass index and body fat distribution. Gynecol. Endocrinol., 10, 17-21.